Annales de Cardiologie et D'angeiologie · Mar 27, 2026
Hyperuricemia is not associated to cardiovascular risk assessed using SCORE2 in non-diabetic hypertensive patients aged 40 to 69 years in North Cameroon
By Hamadou B, Danwe D, Kamdem F et al.
BACKGROUND: Hypertension in a public health problem in Cameroon. Its adequate management involves the assessment of global cardiovascular risk. This assessment is not always feasible using recommended methods. OBJECTIVE: Assess the association between hyperuricemia and SCORE2 cardiovascular risk in non-diabetic hypertensive patients aged 40 to 69 years in North Cameroon. PATIENTS AND METHODS: We conducted a cross-sectional study using a 2022-2023 screening database of employees of an agroindustry. Hyperuricemia was defined as serum uric acid level greater than 70mg/L or a past history of gout. Hypertension was defined as a systolic blood pressure greater or equal to 140mmHg and/or a diastolic blood pressure greater or equal to 90mmHg. We calculated cardiovascular risk using SCORE2. Statistical analysis was done using SPSS version 20.0. RESULTS: We included 588 participants (97.3% men) with a median age of 50 years [46-54]. Most patients had either a high (64.1%) or very high (34.7%) estimated cardiovascular risk. There was no significant difference in the median SCORE2 in patients with or without hyperuricemia. CONCLUSION: Hyperuricemia is not associated to cardiovascular risk in a group of non-diabetic hypertensive patients in North Cameroon. However, our sample is not representative of the general population with hypertension.
doi.org/10.1016/j.ancard.2026.102010PubMed 41904884Biomarkers